Business

RGT Executes Global CannEpil Licensing Deal for US$5.5M

RGT Executes Global CannEpil Licensing Deal for US$5.5M

Argent Biopharma LtdJuly 6, 20263

RGT Executes Global CannEpil Licensing Deal for US$5.5M

About this update from Argent Biopharma Ltd

Argent Biopharma Ltd has released a press release. View Attachment

View stock analysis, news, and events for Argent Biopharma Ltd

More from Argent Biopharma Ltd

Appendix 4E and 2026 Annual Report

August 31, 2026

FDA-CVM Establish INAD File for CannEpil Veterinary Program

August 25, 2026

All Argent Biopharma Ltd news →